Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00227903 · ClinicalTrials.gov registry record · Phase 2
Therapeutic Substance Abuse Treatment in Pregnancy - 1
A Phase 2 study of Alcohol Abuse and Cocaine Abuse, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 168
- Enrollment target
- 2
- Study locations
NCT00227903: Completed Phase 2 study of Alcohol Abuse and Cocaine Abuse, sponsored by Yale University.
NCT00227903 is a Phase 2 study of Alcohol Abuse and Cocaine Abuse that has completed, run by Yale University. The registered enrollment target is 168 participants, below the 709-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (76% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00227903, a Phase 2 study of Alcohol Abuse and Cocaine Abuse, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 168 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is... To assess whether a behavioral treatment that combines motivational enhancement and cognitive skills training therapy (MET-CBT) is more effective than brief advice in: 1) decreasing use of a full range of psychoactive substances (e.g. marijuana, cocaine, methamphetamines, alcohol, nicotine, opioids) in pregnant substance using and dependent women; 2) decreasing HIV risk behavior; 3) improving birth outcomes (longer gestations and greater birth weight).
Conditions Studied
Interventions
- BEHAVIORAL MI-CBT
- BEHAVIORAL Brief Advice
Study Locations (2)
Connecticut
- Bridgeport Hospital - Bridgeport
- Yale-New Haven Hospital - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2004-09 |
| Est. Completion | 2010-08 |
| Phase | Phase 2 |
What the finished NCT00227903 record still lists
NCT00227903 is an interventional study that assigns participants to a tested intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap, below the 709-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (76% lower).
The record links to 3 conditions, with Alcohol Abuse appearing as the primary indexed condition, and to 2 interventions - of which MI-CBT is the first listed.
NCT00227903 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT00227903 about?
NCT00227903 is a clinical study titled "Therapeutic Substance Abuse Treatment in Pregnancy - 1". The purpose of this study is... To assess whether a behavioral treatment that combines motivational enhancement and cognitive skills training therapy (MET-CBT) is more effective than brief advice in: 1) decreasing use of a full range of psychoactive substances (e.g. marijuana, cocaine, methamphetami...
What is the current status of trial NCT00227903?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 168 participants. The study started on 2004-09. Estimated completion is 2010-08.
What conditions does trial NCT00227903 study?
This clinical trial studies the following conditions: Alcohol Abuse, Cocaine Abuse, Marijuana Abuse.
What interventions are being tested in trial NCT00227903?
The interventions under investigation include: MI-CBT (BEHAVIORAL), Brief Advice (BEHAVIORAL).
Who is sponsoring clinical trial NCT00227903?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00227903 being conducted?
This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00227903's enrollment target sits among peer trials
168 22nd of 46 higher than 25 of 46 other Alcohol Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
RECRUITING · Phase 2
-
A Placebo-Controlled Trial of Memantine for Alcohol Dependence
COMPLETED · Phase 2
-
Antioxidant Replacement Therapy in Patients With Alcohol Abuse
COMPLETED · Phase 2
-
Mifepristone Treatment of Alcohol Use Disorder
COMPLETED · Phase 2
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
- NCT03536897 · 168 participants
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
- NCT04078230 · 168 participants · NA
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
- NCT04159168 · 168 participants · NA
Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia